
MicroTex is a pioneering initiative, a collaboration between The University of Edinburgh, Heriot-Watt University, and The University of Bath. It focuses on developing advanced technologies to transform the development of new therapies for infections and inflammation. By integrating expertise from physics, chemistry, biology, engineering, robotics, artificial intelligence, and clinical medicine, MicroTex is creating powerful new tools for experimental medicine and microdosing techniques. These methods involve delivering tiny amounts of drugs to precise locations within the body and rapidly assessing their effectiveness, aiming to streamline clinical trials, reduce animal testing, and expedite the availability of new therapies. MicroTex is committed to addressing antimicrobial resistance and enhancing global health outcomes through groundbreaking research and technological innovation.

MicroTex is a pioneering initiative, a collaboration between The University of Edinburgh, Heriot-Watt University, and The University of Bath. It focuses on developing advanced technologies to transform the development of new therapies for infections and inflammation. By integrating expertise from physics, chemistry, biology, engineering, robotics, artificial intelligence, and clinical medicine, MicroTex is creating powerful new tools for experimental medicine and microdosing techniques. These methods involve delivering tiny amounts of drugs to precise locations within the body and rapidly assessing their effectiveness, aiming to streamline clinical trials, reduce animal testing, and expedite the availability of new therapies. MicroTex is committed to addressing antimicrobial resistance and enhancing global health outcomes through groundbreaking research and technological innovation.